PneumoMab(Pamlico Biopharma)

N/A

Report date: 2023/04/25 09:12:54

QIDP

Base Information

Drug NamePneumoMab(Pamlico Biopharma)

Drug Alias NameFully human IgG antibodies(Pamlico Biopharma)

ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Monoclonal antibody humanized

Mechanisms of ActionImmunoglobulin G modulators

TargetsImmunoglobulin G

Therapy Area/IndicationsInfections

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusPending

Highest Status in ChinaN/A

China Registration ClassN/A

Active CompaniesN/A

Inactive CompaniesN/A

Active IndicationsN/A

Inactive IndicationsInfections

ATC CodeN/A